Tarsus Pharmaceuticals (TARS) Stock Price
$49.36 0%
to add to portfolio
AI Score
-
Alternative
8 -
Fundamental
7 -
Technical
4
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Tarsus Pharmaceuticals, AI stock picks, stock alerts and much more.
TARS AI Stock Analysis
Financial Performance
Tarsus Pharmaceuticals has shown strong financial performance with its revenue growing by 268% year over year to $48.1M in the last quarter. Similarly, gross profit surged by 278.4% YoY to reach $44.9M, indicating a healthy margin level for the company. However, it's important to note that operating income is still negative at -$25.2M but has improved by 43.4% YoY indicating that the company is working towards profitability.
Stock Price
The stock price of Tarsus Pharmaceuticals is currently trading at $52.69 and has seen an impressive growth of 138.4% YoY and a slight increase of 0.4% in the last month alone which shows investor confidence in the company's prospects despite its negative PE ratio of -14.05 and EPS of -3.75 suggesting high future earnings growth expectations from investors.
Alternative Data Signals
In terms of alternative data signals, web traffic has decreased significantly by -61.% MoM which could be a potential red flag as it might indicate declining interest or engagement with the company's products or services online but this needs further investigation before drawing any conclusions.
On a positive note, job postings have increased significantly by 50% MoM and up by 84.6% YoY signifying business expansion plans while social media followership on Twitter, Instagram and Facebook have also been increasing steadily over time which indicates improving brand awareness among consumers.
Conclusion
In conclusion, based on Tarsus Pharmaceuticals' solid revenue growth, steady stock price appreciation despite current lack of profitability and mixed alternative data signals (increasing job postings & social media followers but decreasing web traffic), the outlook for Tarsus Pharmaceuticals' stock is cautiously bullish.
Note: This AI Stock Analysis is based on data as of January 11. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
Tarsus Pharmaceuticals (TARS) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Tarsus Pharmaceuticals (TARS), currently trading at $49.36, will... Sign up to access price prediction.
About TARS
-
Tarsus Pharmaceuticals, Inc.
-
Symbol
TARS
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
2.1B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$19.97 1.4% |
8 |
 |
Inovio Pharmaceuticals INO |
$2.38 10.2% |
2 |
 |
Moderna MRNA |
$23.51 7.4% |
4 |
 |
Anavex Life Sciences AVXL |
$9.37 2.2% |
5 |
 |
BridgeBio Pharma BBIO |
$51.21 2.6% |
6 |
News
TARS Alternative Data
Web Traffic
Tarsus Pharmaceuticals receives an estimated 28330 monthly visitors to tarsusrx.com, which is up by 65.7% over the last month.
-
Web Traffic
28330
-
Change from Previous Month
65.7%
-
3 Month Change
31.4%
-
YoY Change
31.4%
Facebook Engagement
Tarsus Pharmaceuticals has engaged 6 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
6
-
Daily Change
0%
-
1 Month Change
80.6%
-
3 Month Change
200%
-
YoY Change
200%
Instagram Followers
Tarsus Pharmaceuticals has 1,220 Instagram Followers on its main Instagram account, up by 0.7% over the last month.
-
Instagram Followers
1220
-
Daily Change
0.1%
-
1 Month Change
0.7%
-
3 Month Change
3.4%
-
YoY Change
3.4%
LinkedIn Followers
28,542 are following Tarsus Pharmaceuticals on LinkedIn, up by 1.9% over the last month.
-
LinkedIn Followers
28542
-
Daily Change
0%
-
1 Month Change
1.9%
-
3 Month Change
6.2%
-
YoY Change
6.2%
Job Postings
Tarsus Pharmaceuticals has an estimated 11 open job postings, which is down -35.3% over the last month.
-
Job Postings
11
-
Daily Change
0%
-
1 Month Change
35.3%
-
3 Month Change
52.2%
-
YoY Change
52.2%
LinkedIn Employees
According to LinkedIn, Tarsus Pharmaceuticals has 368 employees, up by 0.3% over the last month.
-
LinkedIn Employees
368
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
3.7%
-
YoY Change
3.7%
Reddit Mentions
Tarsus Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
0%
Twitter Followers
Tarsus Pharmaceuticals has 626 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.2% over the last month.
-
Twitter Followers
626
-
Daily Change
0.2%
-
1 Month Change
0.2%
-
3 Month Change
1.1%
-
YoY Change
1.1%
Business Outlook
According to employee reviews, the business outlook among employees at Tarsus Pharmaceuticals is 100 out of 100 (very bullish).
-
Business Outlook
100
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Tarsus Pharmaceuticals was mentioned 2 times in the news yesterday.
-
News Mentions
2
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
TARS Financials
TARS Key Metrics
-
Total Revenue
$78.3M
-
Net Income
-$25.1M
-
Earnings per Share
-$0.64
-
Free cash flow
-$21.2M
-
EBITDA
-$26.3M
-
EBITDA Ratio
-0.335482
-
Total Assets
$500.8M
TARS 2-year Revenue & Income
TARS 2-year Free Cash Flow
TARS Technicals
TARS SMA
TARS RSI
FAQ
What's the current price of Tarsus Pharmaceuticals (TARS) Stock?
The price of an Tarsus Pharmaceuticals (TARS) share is $49.36.
What's the market cap of Tarsus Pharmaceuticals?
The current market cap of Tarsus Pharmaceuticals is 2.1B.
What are some stocks similar to Tarsus Pharmaceuticals (TARS) that investors often compare it to?
Tarsus Pharmaceuticals (TARS) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Tarsus Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Tarsus Pharmaceuticals' stock price to be around $53.89 in 2026. Starting from the current price of $49.36, this represents a 9.2% change in price, indicating a bullish outlook for the stock.
How to buy Tarsus Pharmaceuticals (TARS) Stock?
Tarsus Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Tarsus Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.